e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Late-Breaking Abstracts Session: New treatments and targets for airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late-breaking abstract: Local and systemic distribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure
A. Turowska, N. Baumgartl, J. Kuhlmann, H. Garn (Marburg, Germany)
Source:
Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease
Session:
Late-Breaking Abstracts Session: New treatments and targets for airway disease
Session type:
Oral Presentation
Number:
4493
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Turowska, N. Baumgartl, J. Kuhlmann, H. Garn (Marburg, Germany). Late-breaking abstract: Local and systemic distribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure. Eur Respir J 2011; 38: Suppl. 55, 4493
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Late-breaking abstract: Further studies on the mechanism of action of doxofylline
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Year: 2011
Late-breaking abstract: Changes in cortisol levels in the plasma of asthmatic individuals undergoing allergen inhalation challenge differentiate isolated early from dual responders
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Year: 2011
Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology
Source: Eur Respir J 2001; 18: 246
Year: 2001
New method of treatment of steroid-dependant asthma with inhalations of ultra-low doses of alkylating drug: clinical results
Source: Eur Respir J 2001; 18: Suppl. 33, 50s
Year: 2001
Late-breaking abstract: Pneumonia hospitalizations and long-term exposure to air pollution: A cohort study
Source: Annual Congress 2011 - Outdoor air pollution studies
Year: 2011
Repeated daily inhalations of ciclesonide, compared to single inhalation, do not lead to increased systemic exposure
Source: Eur Respir J 2003; 22: Suppl. 45, 282s
Year: 2003
Advantageous toxicity profile of novel inhaled antisense oligonucleotides, TPI ASM8 and TPI 1100, following chronic dosing in monkeys
Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD
Year: 2008
Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology
Source: Eur Respir J 2001; 17: 157-158
Year: 2001
Inhalation of thoron (Tn) gas in controlled conditions of high background radiation (HBR) using natural thorium: Radioactive dose deposition and acute pneumocystis changes in mouse
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Does aerosol particle size predict lung dose in children?
Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring
Year: 2010
Single dose pharmacokinetics of C16TR for Inhalation (INS1009) vs treprostinil inhalation solution
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Systemic exposure and lung bioavailability across two different dose strengths of CHF5993 a novel Triple pMDI
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
Late-breaking abstract: Lung recruitment in normal and emphysematous rats during methacholine challenge
Source: Annual Congress 2011 - Innovative methods in clinical physiology
Year: 2011
How pharmacokinetic/pharmacodynamic science informs dosage recommendations?
Source: Annual Congress 2010 - PG17 GRACE Postgraduate Course: Antimicrobial treatment of LRTI: important new aspects for clinical practice
Year: 2010
Late-breaking abstract: Inhaled calcium salts reduce tobacco smoke induced airway inflammation and improve lung pathology
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease
Year: 2011
Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid
Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease
Year: 2010
Late-breaking abstract: Genome-wide association of
GLCCI1
with asthma steroid treatment response
Source: Annual Congress 2011 - Phenotyping asthma: a clue for treatments?
Year: 2011
Asthma guidelines: state of the evidence
Source: Annual Congress 2010 - PG20 Postgraduate Course: Implementing asthma guidelines for children in daily practice
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept